Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Amlodipine
Drug ID BADD_D00121
Description Amlodipine, initially approved by the FDA in 1987, is a popular antihypertensive drug belonging to the group of drugs called _dihydropyridine calcium channel blockers_. Due to their selectivity for the peripheral blood vessels, dihydropyridine calcium channel blockers are associated with a lower incidence of myocardial depression and cardiac conduction abnormalities than other calcium channel blockers [A175327]. Amlodipine is commonly used in the treatment of high blood pressure and angina. Amlodipine has antioxidant properties and an ability to enhance the production of nitric oxide (NO), an important vasodilator that decreases blood pressure [A175321]. The option for single daily dosing of amlodipine is an attractive feature of this drug [FDA label].
Indications and Usage For the treatment of hypertension and chronic stable angina.
Marketing Status Prescription; Discontinued
ATC Code C08CA01
DrugBank ID DB00381
KEGG ID D07450
MeSH ID D017311
PubChem ID 2162
TTD Drug ID D08JIV
NDC Product Code 52652-5001; 46287-035
Synonyms Amlodipine | Amlodipine, (+-)-Isomer | Amlodipine Besylate | Amlodipine, (+-)-Isomer, Maleate (1:1) | Amlodipine, (S)-Isomer, Maleate (1:1) | Amlodis | Astudal | Norvasc | Istin | Amlor | Amlodipine Maleate | Amlodipine Maleate (1:1) | Amlodipine, (R)-Isomer
Chemical Information
Molecular Formula C20H25ClN2O5
CAS Registry Number 88150-42-9
SMILES CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Parosmia22.04.03.007; 17.04.04.002--Not Available
Pemphigoid23.03.01.004; 10.04.02.0020.000016%Not Available
Peripheral ischaemia24.04.03.0020.000012%
Peripheral vascular disorder24.03.01.003--Not Available
Photopsia17.17.01.006; 06.02.06.0040.000046%
Platelet count decreased13.01.04.001--
Platelet disorder01.08.03.0010.000031%Not Available
Pleural effusion22.05.02.0020.000092%
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Pneumonia aspiration22.01.01.0050.000020%Not Available
Pollakiuria20.02.02.0070.000123%
Polyuria20.02.03.0020.000031%Not Available
Presyncope17.02.05.009; 02.01.02.007; 24.06.02.0100.000092%
Proteinuria20.02.01.0110.000107%
Pruritus23.03.12.0010.000307%
Pseudolymphoma01.09.01.0160.000031%Not Available
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Pulmonary oedema22.01.03.003; 02.05.02.0030.000215%
Purpura24.07.06.005; 23.06.01.004; 01.01.04.003--
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Rash erythematous23.03.06.0030.000046%Not Available
Rash generalised23.03.13.0020.000077%Not Available
Rash macular23.03.13.0030.000031%Not Available
Rash maculo-papular23.03.13.004--
Rash papular23.03.13.0170.000061%Not Available
Rash pruritic23.03.12.0020.000046%Not Available
Rectal haemorrhage24.07.02.018; 07.12.03.0010.000092%
Red blood cell count decreased13.01.05.0070.000046%Not Available
Renal cyst20.01.04.001; 16.27.01.0010.000031%Not Available
The 11th Page    First    Pre   11 12 13 14 15    Next   Last    Total 17 Pages